LFMD official logo LFMD
LFMD 3-star rating from Upturn Advisory
LifeMD Inc (LFMD) company logo

LifeMD Inc (LFMD)

LifeMD Inc (LFMD) 3-star rating from Upturn Advisory
$3.23
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/19/2025: LFMD (3-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 3 star rating for performance

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Number of Analysts

2 star rating from financial analysts

8 Analysts rated it

Limited analyst coverage, niche firm, research info may be scarce.

1 Year Target Price $9.25

1 Year Target Price $9.25

Analysts Price Target For last 52 week
$9.25 Target price
52w Low $3.21
Current$3.23
52w High $15.84

Analysis of Past Performance

Type Stock
Historic Profit 175.22%
Avg. Invested days 35
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 5.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/19/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 155.48M USD
Price to earnings Ratio -
1Y Target Price 9.25
Price to earnings Ratio -
1Y Target Price 9.25
Volume (30-day avg) 8
Beta 1.36
52 Weeks Range 3.21 - 15.84
Updated Date 12/21/2025
52 Weeks Range 3.21 - 15.84
Updated Date 12/21/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.25

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -3.21%
Operating Margin (TTM) -3.27%

Management Effectiveness

Return on Assets (TTM) -2.85%
Return on Equity (TTM) -2243.07%

Valuation

Trailing PE -
Forward PE 14.73
Enterprise Value 138459111
Price to Sales(TTM) 0.62
Enterprise Value 138459111
Price to Sales(TTM) 0.62
Enterprise Value to Revenue 0.55
Enterprise Value to EBITDA 20.65
Shares Outstanding 48135885
Shares Floating 39176353
Shares Outstanding 48135885
Shares Floating 39176353
Percent Insiders 15.03
Percent Institutions 43

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

LifeMD Inc

LifeMD Inc(LFMD) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

LifeMD, Inc. (formerly eHealth-Services, Inc.) was founded in 2014. The company has undergone significant transformation, rebranding to LifeMD in 2020 and focusing on a direct-to-consumer telehealth model. Key milestones include the expansion of its digital health platform and strategic acquisitions aimed at broadening its service offerings and patient reach.

Company business area logo Core Business Areas

  • Telehealth Platform: LifeMD operates a comprehensive telehealth platform that connects patients with licensed healthcare providers for virtual consultations, diagnoses, and treatment plans. This includes prescription management and chronic care services.
  • Specialty Care: The company offers specialized care in areas such as weight management, men's health, women's health, dermatology, and mental health, leveraging its telehealth infrastructure.
  • Pharmacy Services: LifeMD partners with pharmacies to facilitate the fulfillment of prescriptions generated through its telehealth services, offering convenience to patients.

leadership logo Leadership and Structure

LifeMD is led by a management team responsible for strategic direction and operational execution. The company is structured to support its telehealth services, with dedicated teams for clinical operations, technology development, marketing, and patient support.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • Weight Management Program: A comprehensive telehealth program focused on weight loss, including consultations with healthcare providers, personalized treatment plans, and prescription medication when appropriate. Competitors include companies like Ro, Hims & Hers, and numerous traditional weight loss clinics and programs.
  • Dermatology Services: Virtual dermatology consultations for diagnosis and treatment of various skin conditions, including prescription services for topical and oral medications. Competitors include Apostrophe, SkyMD, and other specialized telehealth dermatology providers.
  • Men's Health Services: Telehealth services addressing common men's health issues such as erectile dysfunction, hair loss, and testosterone replacement therapy. Key competitors include Hims, Ro, and Lemonaid Health.

Market Dynamics

industry overview logo Industry Overview

The telehealth and digital health industry is experiencing rapid growth, driven by increasing patient demand for convenient, accessible, and affordable healthcare solutions. Factors such as technological advancements, favorable regulatory environments, and the ongoing need for chronic disease management contribute to this expansion. The market is characterized by increasing competition from both established healthcare providers and innovative tech companies.

Positioning

LifeMD is positioned as a direct-to-consumer telehealth provider offering a broad range of specialized care services through its digital platform. Its competitive advantages lie in its integrated model, encompassing virtual consultations, prescription fulfillment, and a focus on chronic care management. The company aims to differentiate itself through its brand, patient experience, and the breadth of its service offerings.

Total Addressable Market (TAM)

The global digital health market is projected to reach hundreds of billions of dollars in the coming years. LifeMD is positioned to capture a portion of this TAM by focusing on specific chronic and specialized care segments within the broader telehealth market. Its success depends on its ability to scale its patient base, expand its service offerings, and compete effectively against a growing number of players.

Upturn SWOT Analysis

Strengths

  • Established telehealth platform with a focus on specialized care.
  • Integrated model including virtual consultations and pharmacy services.
  • Brand recognition within the direct-to-consumer telehealth space.
  • Ability to scale operations through technology.

Weaknesses

  • Reliance on third-party pharmacies for prescription fulfillment.
  • Potential for increased regulatory scrutiny in the telehealth space.
  • Brand perception and trust-building challenges in a competitive market.
  • High marketing and customer acquisition costs.

Opportunities

  • Expansion into new therapeutic areas and specialized services.
  • Partnerships with employers, insurers, and healthcare systems.
  • Leveraging data analytics for personalized patient care and operational efficiency.
  • International market expansion.

Threats

  • Intensifying competition from both established players and new entrants.
  • Changes in telehealth regulations and reimbursement policies.
  • Data privacy and cybersecurity risks.
  • Economic downturns affecting consumer spending on healthcare services.

Competitors and Market Share

Key competitor logo Key Competitors

  • Ro (RO)
  • Hims & Hers Health, Inc. (HIMS)
  • Teladoc Health, Inc. (TDOC)
  • Amwell Corporation (AMWL)
  • MDconnect (Private)

Competitive Landscape

LifeMD faces intense competition from both pure-play telehealth providers and established healthcare entities venturing into digital health. Its advantages lie in its specialized care focus and integrated model. However, it contends with larger players with greater resources, brand recognition, and established patient networks. Differentiating its service quality and patient experience is crucial for maintaining and growing its market share.

Growth Trajectory and Initiatives

Historical Growth: LifeMD has experienced substantial historical growth, primarily driven by its expansion in the direct-to-consumer telehealth market and strategic acquisitions. This growth has been characterized by increasing patient acquisition and revenue figures.

Future Projections: Future growth projections for LifeMD are typically based on analyst estimates that consider market trends, company-specific strategies, and competitive pressures. These projections often anticipate continued expansion in existing service lines and the introduction of new offerings.

Recent Initiatives: Recent initiatives may include platform enhancements, expansion into new therapeutic areas, marketing campaigns to increase brand awareness, and partnerships aimed at broadening its reach and service capabilities.

Summary

LifeMD Inc. operates within the rapidly expanding telehealth sector, offering specialized care through its digital platform. The company has demonstrated strong revenue growth and has a clear strategic focus on expanding its service offerings and patient reach. However, it faces significant competition, high customer acquisition costs, and regulatory uncertainties, which are key areas to monitor for its future success.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Company investor relations websites
  • Financial news outlets
  • Market research reports
  • SEC filings (e.g., 10-K, 10-Q)

Disclaimers:

This analysis is based on publicly available information and is for informational purposes only. It does not constitute investment advice. Financial data and market share figures are estimates and may vary. Investors should conduct their own due diligence before making any investment decisions.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About LifeMD Inc

Exchange NASDAQ
Headquaters New York, NY, United States
IPO Launch date 2001-01-02
Chairman & CEO Mr. Justin Schreiber
Sector Healthcare
Industry Health Information Services
Full time employees 304
Full time employees 304

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology. It also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. Further, it offers GLP-1 for weight management and in-home health monitoring devices. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.